Borna disease virus (BDV),
preferentially targets neurons of limbic structures 2 causing behavioral abnormalities in animals.
3,4 Markers 5-10 and virus [11] [12] [13] in patients with affective disorders and schizophrenia have raised worldwide interest. 3 A persistent infection was suggestive from follow-up studies, 5,14 but inconstant detectability weakened a possible linkage. 15 This study for the first time discloses that detection gaps are caused by BDV-specific circulating immune complexes (CIC), and their interplay with free antibodies and plasma antigens (p40/p24). Screening 3000 sera each from human and equine patients over the past 4 years by new enzyme immunoassays (EIAs) revealed that BDV-CICs indicate 10 times higher infection rates (up to 30% in controls, up to 100% in patients) than did previous serology. 16, 17 Persistence of high amounts of CICs and plasma antigens correlates with severity of depression. Even BDV RNA could be detected in plasma samples with strong antigenemia. Our discovery not only explains the course of persistent infection, but offers novel easy-to-use diagnostic tools by which new insights into BDV-related etiopathogenesis of disease and epidemiology are possible. Molecular Psychiatry (2001) 6, 481-491.
CICs had predominantly been studied for their pathogenic role, namely vascular damage, in autoimmune diseases 18 and chronic viral infections (CMV, EBV, HBV, HIV). 19, 20 In contrast low replication and infection rates of BDV in blood cells 21 concealed possible CIC formation.
Longitudinal studies 5, 11, 14 led to the discovery of BDV-specific CICs and their general occurrence during the human and animal infection described here, which plausibly resolves previous diagnostic discrepancies. 15 Unlike non-specific CIC-assays, 22 an easy enzyme immune assay (EIA) with specifically immobilized anti-p40/p24 monoclonal antibodies (moAbs) 23 trapping antigen of BDV-CICs from plasma, was developed.
The antibody-part was identified by enzyme-labeled anti-species IgG.
This assay was evaluated over 4 years by screening 3000 plasma samples each from human and equine patients/controls, parallel to previous methods, like antibody detection by immunofluorescence (Ab-IF), 17 and cell-antigen (cAg) by EIA in corresponding PBLs. 11 Surprisingly, p40/p24-CICs represented the most prevalent markers in humans and animals. In patients with different severity and types of depression (n = 290), randomly selected from a total of 787 from independent university clinics ( Figure 1 ), CICs were present in 62% and 52%, as compared to 11% and 20% of Ab-IF, and to 15% and 23% of cAg (infection rate ෂ70%) ( Figure 2 ). CIC determination implicated a considerably higher infection prevalence than previous serology. 16, 17 In healthy controls (n = 100), CIC rates (24%) exceeded the Ab-IF-rates (2%) 10-fold, whereas cAg was lacking (Figures 1, 2 ).
Sensitivity and specificity of BDV-CICs were further proven by standard methods. 20, 22, 24 PEG-treated CICs gave EIA results concordant with untreated samples, but required 10 times higher initial concentrations. No BDV-CICs were obtained from EIA-negative samples (data not shown). By the above procedure, BDV p40 and p29 (which is part of the p24-dimer 1 ) could be demonstrated (Figure 3a) . After CIC-isolation from strongly positive patients with either depression (patient DR) or Obsessive Compulsive Disorder (OCD; patient WK) using protein G-affinity-chromatography, BDV p40 and p24 was demonstrated by Western-blotting (Figure 3b and c) .
In that chronically depressed patient, individual CICs detected either by anti-N(p40) or anti-P(p24) moAbs revealed weekly oscillations (Figure 4a ). In practice, both CIC-types could be assayed in one single test, with similar or higher sensitivity. Long-term maintenance of CICs, as representatively shown over half a year (Figure 4b ), seemed to be frequent in chronic courses of depression. The same was true in some OCD 
Figure 2
Comparison of BDV-CICs with previous infection markers. Percent prevalence (one sample per patient) of randomly selected patient groups from two different clinics, presenting with different severity and types of depression (see Figure 1 ; abbreviation of markers, see Table 1 ); statistical significance by 2 -test: CIC prevalence in UKBF-patients vs controls: P Ͻ 0.0001, in MHH-patients vs controls: P Ͻ 0.001. patients (data not shown). The source for continuous CIC formation remained unclear, because of few samples with antigen-positive PBMCs (cAg; Figure 4b ). Therefore, cell-produced antigen must have been released into the blood stream. By progressively mounted antibody response, in turn, CICs were formed and antibodies disappeared. Production of free plasma antigen (pAg) could, indeed, be proven by an EIA test used earlier to demonstrate viral proteins in patients' cerebrospinal fluids (CSFs). 3, 25 The pAg assay may include the detection of naturally formed N/P heteromers. Likewise, an EIA-based antibody assay completed this test triplet, showing the dynamic of BDV infection (Figure 4b ) which seems to be in line with other persistent virus infections. 19 The test triplet showed striking similarities (high CIC-and pAg-values) in horses with severe Borna disease (BD) and humans with severe depression (representative cases; Figure 5 ). To further elucidate the significance of both markers, we re-investigated a group of 28 patients with Major Depressive Disorder (MDD) or Bipolar Disorder (BP), hospitalized due to acute severe depressive crisis 26 ( Figure 1 , Table 1 ). They were compared with 28 moderately depressed, age-and sex-matched outpatients (group II) with the same disorders ( Figure 1 , Table 2 ). In both groups, CIC formation exceeded 90%, approaching 100% infection, whereas Ab-IF and cAg 11, 17 remained at the expected 20% and 40%, respectively. In healthy controls (65 blood donors, group III), CIC rates (32%) represented the most prevalent, often only sign of infection ( Figure 1 , Table 2 ). Despite a mismatch in age and sex compared to patients, these controls perfectly matched with 3% worldwide BDV seroprevalence (Ab-IF) 17 (Table 2, Figure 2 ). With respect to CIC rates, the previously assumed prevalence is exceeded ten times, reflecting the background infection in humans.
Low CIC levels (4.8% with high amounts), low rates (6%) and amounts of free pAg, with no cAg, seemed characteristic for latent sub-clinical infections, whereas high CIC levels, and high rates and amounts of pAg significantly paralleled severe depression in MDD and BP patients. Unlike the same prevalence of Ͼ90% CICpositives, group I, presenting with acute depressive crisis, harbored 30% with high values, vs only 8% in group II with moderate depression. Likewise, an exorbitantly high rate of antigenemia (40%) and pAg- amount (Ͼ80% positives with high values) corresponded with severe MDD or BP (group I), and low frequencies (11%) and amounts (no pAg-positives with high values) with moderate MDD or BP (Table 2) . To estimate pAg-concentrations, a calibration curve of purified native p40 and p24 showed ( Figure 6 ) that the detection limit ranged from 0.3 to 0.5 ng of N-and P-protein (3-5 ng ml ), representing sufficiently sensitive levels compared to other systems. 20 Detectable quantities ranged from 3 to 5000 ng ml −1 . Estimated high antigen levels (Ͼ100 ng ml Moreover, repeated RNA amplification from aliquot specimens was only successful in plasma harboring high antigen levels, derived from seven patients of the former group (Table 1, Figure 1 ). Any molecular work was performed with double-coded samples, at different time points and locations other than for immune assays (Tables 1 and 2) . Surprisingly, sequencing of 35.3% of ORF-p40 (genomic nucleotides [nt] 320-711) and 36.7% of ORF-p24 (nt 1571-1791) revealed identical mutations, with 0.77% and 2.26% divergencies to strain V, 27 respectively. According to other human-and animal-derived gene bank sequences (n = 30, ORF-p40; n = 44, ORF-p24), two mutations each were rare 28 (nt 464 and 542, nt 1668 and 1721) ( Table 3 ), but they were also found in brain samples of a horse which had died from natural BD. Speculative explanations might attribute these mutations to predominant RNA quasi species, or to commonly virulent strains. 3 This first report on CICs, plasma antigens, and plasma RNA in BDV infection allows new interpretations of human infections and disease, explaining previous discrepant results. 28, 29 The rapid and easy CICassay does not require PEG concentration. Interference with free plasma antigen is negligible, due to the 10 times difference in dilutions. Thus, the novel test triplet (CICs, pAg, Abs) represents a powerful tool for BDV diagnostic.
The results indicate BDV-CICs as general phenomena in infected humans and animals, representing pre-Molecular Psychiatry Table 1 ). Values are given as extinction at 405 nm, measured in the starting dilutions for each test (see Materials and methods).
Figure 5
Comparative analysis of antigenemia, antibodies, and CICs determined in representative samples of human patients and diseased horses (one sample per subject). Horses presented with clinical symptoms of BD (mainly apathy, somnolence), sample of horse On taken close to death, of horse Sc taken 5 days after onset of acute disease, and of horse Ba during disease development; samples of severely depressed patients S-29, S-31, and S-12 (see Table 1 ) were from days 4, 7, and 14 at hospital, respectively. dominant markers. CIC formation appears to be the consequence of alternately replicating BDV, leading to short-term antigen-positive PBLs, antigen release into the blood (cell sources unclear), and induction of antibodies, the latter two forming CICs. This first discovery of BDV-CICs allows realistic estimations of infection prevalence which is ten times higher than previously assumed, 17 fitting in with the concept of BDV as a welladapted old virus. 3 A low pathogenicity (3-4%) in vulnerable human subjects 30 can be postulated, considering a world-wide life-time prevalence of recurrent affective disorders of at least 1%, and almost 100% infection found in such patients, vs up to 30% of asymptomatic carriers. An etiopathogenic role of BDV in mood disorders seems considerably strengthened, given the significant coincidence of severe disease and antigenemia, in the presence of high CIC values. High amounts of free antigens, also detectable in CSFs of MDD patients, 25 are prerequisites for the hypothesized pathomechanism of an interference of viral components with neurotransmitter receptors, 2 thus disturbing the sensitive balance of neuronal circuits.
11 Viral RNA accompanying high antigenemia (possibly as ribonucleoproteins [RNPs] 1 ), appeared to be inconsistent and rare. Whether long-term maintenance of BDV-CICs could account for known kinds of IC-diseases, 19 remains elusive.
Materials and methods

Patients
Between June 1996 and April 1999, 3063 psychiatric patients were screened, of whom 787 either consulted the Psychiatric Clinic of the Free University Hospital Benjamin Franklin in Berlin (UKBF; n = 221), or the Psychiatric Department of the Medical School of Hanover (MHH; n = 566), as potential participants of clinical studies. Here, randomly selected sub-cohorts of period January 1997 to October 1998 were presented, namely 187 outpatients from the UKBF and 103 in/outpatients from the MHH, both groups diagnosed as having affective disorders. In addition, serial plasma samples (stored −20°C) from clinically intensely studied patients with severe MDD or BP (n = 39), who had been admitted to the Crisis Intervention Center at UKBF between June 1993 and August 1994, 26 were reinvestigated. We also included 100 out of 200 randomly selected blood donors (collected June 1998) from the German Red Cross (DRK, Berlin), who were tested negative for hepatitis B-and C-virus and HIV. Finally, BDV-RNA analyses of 533 plasma samples from 121 patients of the above groups and of 65 healthy donors were performed between May 1998 and April 2000 (overview in Figure 1 ).
Animals
Between August 1995 and July 1999, blood samples of 3282 horses, the majority sent from practitioners and horse clinics, were screened to exclude or confirm BDV infection (Ab-IF, cAg, CIC). From this background experience of 4-years-evaluation of CIC-and additional Table 1 . Statistical significance by 2 -test, ns = no significant difference.
Note: Given the above infection prevalence determined by at least one positive of six different assays, the CIC assay alone detected 92.9% (26/28) of infections in acutely depressed patients, and 95.5% (21/22) of (latent) infections in healthy donors, by one sample per subject analysis. pAg-testing in animals, the results of which would be beyond the scope of this paper, only data from single but representative cases were included, because of the striking analogy to human patients (see Figures 3, 5) .
Blood samples
Citrated blood samples (10 ml), collected at the above clinical institutions and mailed to our laboratory at the Molecular Psychiatry Figure 1 ): mean number of samples were 4.0 ± 2.4 (severe group), 4.2 ± 2.4 (moderate group, UKBF), 3.6 ± 1.4 (moderate group, MHH); in the same sequence: mean ages were 50.5 ± 17.0 years, 51.9 ± 11.3 years, 50.1 ± 12.1 years; male to female ratios were 26.3-73.7%, 28-72%, 37.9-62.1%; BP to MDD ratios were 23.7-76.3%, 40.9-59.1%, and 30.8-69.2%, respectively. Controls were 65 healthy donors (one sample per subject), as described in Table 2 . (b) Comparison of percent amplified RNA from plasma samples with percent antigen-positive plasma samples; patients and controls as described in (a). Statistical significance by 2 -test, pRNA, severe vs moderate UKBF: P Ͻ 0.001; pRNA, severe vs moderate MHH: P Ͻ 0.0001; pAg, severe vs moderate UKBF: P Ͻ 0.001; pAg, severe vs moderate MHH:
Robert Koch-Institut, were separated by density-gradient centrifugation (Ficoll-Paque) 1.077 (human blood) 5 and 1.09 (equine blood) into plasma and PBLs, coded prior to any assay described here, and stored at −20°C.
Isolation and analysis of CICs
Polyethylene glycol (PEG) precipitation of immune complexes was performed as described, 24 with minor modifications. Briefly: 100 l of patient plasma was added to 3.9 ml of a 3.5% (wt/vol) solution of PEG 8000 (Sigma, St Louis, MO, USA) in 0.1 M borate buffer (pH 8.4), and incubated at 4°C for 18 h. The precipitate Table 3 Sequence analysis of repeatedly amplified BDV-RNA from aliquots of blood plasma samples of patients with severe depression (Table 1 4) . The precipitate was washed twice in borate buffer (1952 × g, 10 min), the pellet dissolved in 300 l of 1.5 M glycine (pH 1.85) (1 h at 37°C) as described, 20 and concentrated to half the volume in Centricon YM3 tubes (Millipore Inc, Bedford, MA, USA; cut off 3 kDa (5422 × g, 30 min)). A 30-l aliquot of these dissociated CICs was neutralized with the same volume of 1.5 M Tris/HCl (pH 9.0), immediately boiled in 60 l Lämmli buffer (5 min), and subjected to SDS-PAGE (ready-to-use gradient gels 4-20%, Novex, San Diego, CA, USA), followed by Western-blot analysis. 11 Alternatively to PEGprecipitation, CICs were isolated by protein G-affinitychromatography. Plasma samples (0.5 ml each) were mixed with equal volumes of sample buffer (PBS, pH 7.0 + 5 mM EDTA) and applied to a column with protein G-Sepharose 4 Fast Flow (Amersham Pharmacia Biotech, Buckinghamshire, UK) (bed volume 1 ml). After removing unbound sample components (10 ml wash with sample buffer), bound CICs were eluted with 3 ml and additional 2 ml elution buffer (0.1 M glycine-HCl, pH 2.5). Collected fractions of 1 ml, neutralized with 1 M Tris/HCl, pH 9.0 and optionally treated with 7 M urea, were size-fractionated by SDS-PAGE (10% or 12% gels) and analyzed by Westernblotting. 11 For both CIC-isolation-methods, blotted BDV-specific antigens were identified by the same rabbit hyper-immune serum (EV 3). 23 
Enzyme immuno assays (EIAs)
Following the concept of maximum versatility, all EIAs including the CIC test used the same solid phase support, volume per well (100 l), and buffers, and the same initial coating steps (1 and 2), described in detail below.
CIC assay
CICs were determined as follows: (Step 1) polystyrene microtiter formate Maxisorp Immuno Modules (Nunc, Roskilde, Denmark) were coated with 1.8 g ml −1 of AffiniPure Goat Anti-Mouse IgG, FcFragment-specific (adsorbed against human, bovine, equine serum proteins), in 10 mM sodium phosphate and 250 mM sodium chloride, pH 7.6, for 1 h at 37°C (or overnight at 4°C). Antigen assays BDV antigens p40 and p24 expressed inside PBLs (cAg) 5, 11 or present in blood plasma (pAg; p40/p24 heteromers included) were determined by the following EIA-protocol: (Steps 1 and 2) as CIC assay. (Step 3) after washing, ultrasonicated PBL 11 or native plasma samples, diluted 1:2 and serially two-fold in PBS-T, were incubated for 2 h at 37°C or overnight at 4°C. (Step 4) after washing, polyclonal rabbit anti-BDV serum (IF-titer 1:10 000), 23 diluted 1:1000 in PBS-T, was incubated for 2 h at 37°C. (Step 5) after washing, AP-conjugated AffiniPure Goat Anti-Rabbit IgG, FcFragment-specific (adsorbed against human serum proteins), diluted 1:3000 in TBS-T was incubated for 1 h at 37°C. After washing, steps 5 and 6 of CIC assay.
Antibody assays BDV antibodies in blood plasma were determined by immunofluorescence (Ab-IF) as described previously ), diluted 1:300 in PBS-T, were incubated overnight at 4°C. (Step 4) after washing, plasma (or serum) samples, diluted 1:100 and serially two-fold in PBS-T, were incubated for 2 h at 37°C. After washing, steps 4, 5, and 6 of CIC assay follow.
Isolation and quantitative determination of BDVspecific antigens
Native N-and P-proteins were purified from 20% (w/v) brain suspension of a horse with BD by stepwise centrifugation at 4°C (10 min at 1000 × g, 10 min at 15 000 × g, 1 h at 100 000 × g). From the 10-fold concentrated supernatant (10 h, 5000 × g, 4°C; Centricon 10-tubes, Millipore Corporation, Bedford, MA, USA), the proteins were isolated by affinity chromatography, using the above moAbs (see CIC assay) which were cross-linked to protein G-Sepharose 4 Fast Flow beads (1 mg ml −1 ) (Amersham Pharmacia Biotech, Buckinghamshire, UK) by dimethyl suberimidate (22 mM in 0.2 mM disodium tetraborate/NaOH, pH 9.0). Elution was done by a linear concentration gradient from 0 mM to 2000 mM of aqueous MgCl 2 solution. Purified N-and P-proteins were used to determine the binding capacity of the antigen assay. Protein concentrations of geometrical dilutions of 0.1 to 90 000 ng ml −1 were measured by spectroscopy at 205 nm (peptide linkage) and 595 nm (Bradford assay) vs serum albumin standards, before and after incubation in microtiter modules coated with moAbs (see step 3, EIAs). The specifically bound protein amount was calculated by subtraction analysis of two corresponding values. The resulting calibration diagram ( Figure 6 ) allows an estimation of pAg concentration in blood samples.
Competitive inhibition of plasma antigen by natural antibodies
Plasma samples from an acutely sick horse, with an EIA-determined antigen content of 1-2 ng per 100 l Molecular Psychiatry were diluted (1:2, 1:4, 1:8, 1:16) in either plasma from an uninfected antibody-negative horse or from an acutely depressed antibody-positive (EIA-determined titer of 1:50 000) human patient. After incubation for 2 h at 37°C, followed by 4°C overnight, the mixtures and the untreated sample were assayed for antigen by EIA (Figure 7 ). This basic experiment has been repeated using different dilutions of either antibody samples.
Genetic analysis of plasma samples
Samples had been stored at −20°C for up to 7 years. Of group I (Table 2 ) which underwent considerable reinvestigation by EIA methods described here, samples had been repeatedly defrosted and frozen prior to molecular analysis.
Total RNA was extracted from 100 l plasma by TRI-ZOL reagent according to instructions of the manufacturer (Life Technologies, Paisley, Scotland, UK), and re-suspended in 50 l RNase-free water. Reverse transcription (RT) of RNA samples, PCR reactions, and primers to amplify ORF p40 and p24 fragments were modifications of a previously published protocol. 5 RNA (2 g in 8 l) was denatured for 4 min at 75°C and reverse transcribed by 200 U M-MLV revertase (Life Technologies) in first strand buffer for 1 h at 37°C, in the presence of 10 mM DTT, 0.2 mM dNTPs (MBI Fermentas), 40 U RNasin (Promega), and 2 M specific (external) primer, in a total volume of 20 l. RT reaction was stopped at 90°C for 5 min. External primers for ORF p40 were 5ЈGTCACGGCGCGATATGTTTC3Ј (242F; 38A) with anti-genomic polarity and 5ЈCTTCTTACTCCAGTAAAACGC3Ј (989R; 38B) with genomic polarity, corresponding to nt 242-989 of the BDV genome. 27 Primers for ORF p24 were 5ЈAGACAC-TACGACGGGAACGA3Ј (1327F; 24A) with anti-genomic polarity and 5ЈTGGGAGCTGGGGATAAATGC3Ј (1838R; P2) with genomic polarity, corresponding to nt 1327-1838 of the BDV genome 27 (Roth GmbH, Germany). In the first PCR (50 l volume), 2 l of the RT product were amplified in the presence of 0.2 mM dNTPs, 0.4 M external primers each (antigenomic + genomic), and 1.25 U Taq polymerase (Perkin Elmer) in PCR buffer mix, by the following cycling protocol: 1 cycle at 95°C for 3 min, then 33 cycles of 94°C for 1 min, 54°C (ORF p40) or 52°C (ORF p24) for 1 min, 72°C for 1.5 min (synthesis), and finishing with 1 cycle at 72°C for 10 min, yielding PCR products of 748 base pairs (bp) and 463 bp of ORF p40 and p24, respectively. In the nested-PCR (50 l volume), 0.5 l of the first PCR were amplified using 0.4 M internal primers and the following alternative cycling protocol: 1 cycle at 95°C for 3 min, then 40 cycles of 94°C for 1 min, 52°C (ORF p40) or 58°C (ORF p24) for 1 min, 72°C for 1.5 min, and finishing with 1 cycle at 72°C for 10 min, yielding nested PCR products of 441 bp and 270 bp of ORF p40 and p24, respectively. Internal primers for ORF p40 were 5Ј-GCCTTGTGTTTCT ATGTTTG3Ј (277F; 186) with anti-genomic polarity and 5ЈATTCTTTACCTGGGGACTCA3Ј (717R; 606) with genomic polarity, corresponding to nt 277-717 in the BDV genome. 27 Internal primers for ORF p24 were 5ЈGCATGATCGAGGCTGAGGAG3Ј (1528F; P3) with anti-genomic polarity and 5ЈGCAACATGGGTGCA-GAGGTC3Ј (1797R; P4) with genomic polarity, corresponding to nt 1528-1797 in the BDV genome. 27 RNA quality controls were done by amplification of the house-keeping gene for ␤-actin as described. 5 BDVspecific nested products detected by ethidium bromide staining were isolated from the reaction mixture by the QIAquick PCR Purification Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. A mixture of 10 l cDNA (500 ng) and 1 l primer solution (10 pmol l ) was used for direct sequencing analysis by ABI377A-Dye Terminator. For each sample the sequence was independently determined in triplicate using the computer program ABI PRISM Model 377 Version 2.1.1. The range of analyzed sequences was 392 bp for the N protein (nt 320-711) and 221 bp for the P protein (nt 1571-1791).
